• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Feb 7;13:817876.
doi: 10.3389/fimmu.2022.817876. eCollection 2022.
Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months


Patricia Kaaijk[SUP] 1 [/SUP], Verónica Olivo Pimentel[SUP] 1 [/SUP], Maarten E Emmelot[SUP] 1 [/SUP], Martien Poelen[SUP] 1 [/SUP], Alper Cevirgel[SUP] 1 [/SUP], Rutger M Schepp[SUP] 1 [/SUP], Gerco den Hartog[SUP] 1 [/SUP], Daphne F M Reukers[SUP] 1 [/SUP], Lisa Beckers[SUP] 1 [/SUP], Josine van Beek[SUP] 1 [/SUP], Cécile A C M van Els[SUP] 1 2 [/SUP], Adam Meijer[SUP] 1 [/SUP], Nynke Y Rots[SUP] 1 [/SUP], Jelle de Wit[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to considerable morbidity/mortality worldwide, but most infections, especially among children, have a mild course. However, it remains largely unknown whether infected children develop cellular immune memory.
Methods: To determine whether a memory T cell response is being developed, we performed a longitudinal assessment of the SARS-CoV-2-specific T cell response by IFN-γ ELISPOT and activation marker analyses of peripheral blood samples from unvaccinated children and adults with mild-to-moderate COVID-19.
Results: Upon stimulation of PBMCs with heat-inactivated SARS-CoV-2 or overlapping peptides of spike (S-SARS-CoV-2) and nucleocapsid proteins, we found S-SARS-CoV-2-specific IFN-γ T cell responses in infected children (83%) and adults (100%) that were absent in unexposed controls. Frequencies of SARS-CoV-2-specific T cells were higher in infected adults, especially in those with moderate symptoms, compared to infected children. The S-SARS-CoV-2 IFN-γ T cell response correlated with S1-SARS-CoV-2-specific serum antibody concentrations. Predominantly, effector memory CD4[SUP]+[/SUP] T cells of a Th1 phenotype were activated upon exposure to SARS-CoV-2 antigens. Frequencies of SARS-CoV-2-specific T cells were significantly reduced at 10 months after symptom onset, while S1-SARS-CoV-2-specific IgG concentrations were still detectable in 90% of all children and adults.
Conclusions: Our data indicate that an antigen-specific T cell and antibody response is developed after mild SARS-CoV-2 infection in children and adults. It remains to be elucidated to what extent this SARS-CoV-2-specific response can contribute to an effective recall response after reinfection.

Keywords: COVID-19; SARS-CoV-2; T cell immunity; adaptive immunity; antibody response; children; cytokines; mild symptoms.
 
Back
Top Bottom